KOOL
$0.36
Cesca Therapeutics I
($.02)
(5.26%)
KOOL
Earnings Whisper ®
N/A
3rd Quarter September 2018
Consensus:  ($0.10)
Revenue:  $2.97 Mil
Monday
Nov 12
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when KOOL reports earnings?
Beat
Meet
Miss

Where is KOOL's stock price going from here?
Up
Flat
Down
Stock chart of KOOL
Analysts
Summary of analysts' recommendations for KOOL
Score
Grade
Pivots
Resistance
$0.41
$0.40
$0.38

$0.37

Support
$0.35
$0.34
$0.33
Tweet
Growth
Description
Cesca Therapeutics Inc. is engaged in the research, development, and commercialization of autologous cell-based therapeutics for use in regenerative medicine. It also develops and manufactures automated blood and bone marrow processing systems and companion disposable products that enable the separation, processing and preservation of cell and tissue therapy products. The Company sells its products in approximately 30 countries throughout the world to customers that include private and public cord blood banks, surgeons, hospitals and research institutions. Cesca Therapeutics Inc., formerly known as ThermoGenesis Corp., is headquartered in Rancho Cordova, California.
Peers
Edwards LifesciencesIntuitive SurgicalAlign TechnologyWright Medical GroupSTERISInvacareCryoLifeRTI SurgicalLakeland Industries